Published date: 11 June 2020

Last edited date: 24 November 2020

This notice was replaced on 11 June 2020

This notice does not contain the most up-to-date information about this procurement. The most recent notice is:

Opportunity (published 11 June 2020, last edited 25 November 2020)

Closed opportunity - This means that the contract is currently closed. The buying department may be considering suppliers that have already applied, or no suitable offers were made.


Contract summary

Industry

  • Pharmaceutical products - 33600000

Location of contract

East Midlands, East of England, London, North East, North West, Scotland, South East, South West, Wales, West Midlands, Yorkshire and the Humber, Northern Ireland

Value of contract

£0 to £2,500,000

Procurement reference

CF-0000600D0O000000rwimUAA2

Published date

11 June 2020

Closing date

14 July 2020

Closing time

12am

Contract start date

1 April 2021

Contract end date

31 March 2022

Contract type

Supply contract

Procedure type

Restricted procedure (above threshold)

A two-stage procedure, where the first stage is used to select suppliers, who are then invited to bid in the second stage.

This procedure can be used for procurements above the relevant contract value threshold.

Contract is suitable for SMEs?

Yes

Contract is suitable for VCSEs?

No

Description

Procurement exercise for a contract(s) for the supply of atropine sulfate solution for injection, ciprofloxacin tablets and solution for infusion and Prussian blue (ferric hexacyanoferrate).

More information

Previous notice about this procurement

Contract for the supply of strategic stockpile of medicines 2021 CM/EMP/15/5473/662

  • Opportunity
  • Published 11 June 2020, last edited 11 June 2020

Links

About the buyer

Contact name

Lynne Nichols

Address

2nd Floor, Rutland House
Runcorn
WA7 2ES
GB

Email

lynne.nichols@dhsc.gov.uk